re: perspective what's the problem? The shares were placed in accordance with ASX rulings and at a fair price at placement time.
The only announcements before and since the placement relate to a board appointment and a manufacturing partner appointment.
The placement notice clearly stated what the money was for and that a marketing campaign would commence next week.
Today's Bird Flu release is surely a prelude to that campaign.
If the company was ramping, would they not have done today's Bird Flu notice BEFORE the placement, seeing as two directors have large holdings?
Today's flurry is just the insiders at the ASX going ballistic at an announcement.
The wider market (who don't sit here staring at chatrooms) seems happy and supporting steady, continued price growth.
- Forums
- ASX - By Stock
- AFT
- release says it all
AFT
afg 2023-1 trust in respect of series 2023-1
Add to My Watchlist
0.00%
!
0.1¢

release says it all, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.020M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AFT (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online